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ABSTRACT 
Colocalization of proenkephalin and prodynorphin mRNAs with each other as well as with 
D1, D2, and D3 dopamine receptor mRNAs was analyzed in the nucleus accumbens of the rat. 
Distinct combinations were detected in the rostral pole, core, and shell subdivisions of the 
nucleus accumbens. Proenkephalin and prodynorphin mRNAs were principally localized in 
separate cells in the core. All detectable prodynorphin cells in the core expressed D1 mRNA but 
not D2 mRNA. Conversely, approximately 95% of the proenkephalin-positive cells in this region 
expressed D2 mRNA but not D1 mRNA. This pattern was identical to that observed in the 
caudate putamen. In the rostral pole and the shell, embedded in a background of this “typical” 
colocalization pattern, clusters of cells expressing a distinct configuration were found. In these 
clusters, proenkephalin-positive cells expressed both prodynorphin and D1 mRNAs, but they 
did not express D2 mRNA. 
D3 and prodynorphin mRNAs were colocalized in “limbic” striatal areas, including the 
ventromedial caudate putamen, the rostral pole, and the medial shell. In contrast, D3 mRNA 
was not detected in any proenkephalin-positive cells. Together with the prodynorphin/Dl data, 
this suggests that a subset of prodynorphin cells expresses both D1 and D3 mRNAs. 
It is concluded that 1) clusters of cells that coexpress proenkephalin, prodynorphin, and D1 
mRNAs overlap extensively with previously defined cytoarchitectural cell clusters in the 
nucleus accumbens and 2) a subset of the prodynorphin cells in the ventromedial caudate 
putamen and the nucleus accumbens contains both D1 and D3 mRNAs. ‘ii 19% Wiley-Liss, Inc. 
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The nucleus accumbens (NAcc) is a major component of 
the ventral striatum (Heimer et al., 1982), which has been 
implicated in a number of functions, including drug rein- 
forcement and locomotor behavior (Koob et al., 1991). 
Dopamine (DA) and the opioid peptides are two neurotrans- 
mitter systems within the NAcc that have been associated 
with these functions (Cooper, 1991). The NAcc is rich in the 
opioid peptides enkephalin (ENK) and dynorphin (DYN) as 
well as DA terminals and DA receptors. Analyses of the DA 
receptor subtypes expressed by ENK and DYN cells have, 
however, focused mainly on the caudate putamen (CPu; 
Gerfen, 1992; Surmeier et al., 1993). The NAcc shares a 
number of neurochemical and anatomical characteristics 
with the CPu, but behavioral studies have indicated that 
these two nuclei are functionally distinct. Furthermore, 
DA-opioid interactions within the NAcc produce distinct 
behavioral effects compared to those of the CPu (for 
references, see Cooper, 1991; Koob et al., 1991; Wise and 
Hoffman, 1992; Bals-Kubik et al., 1993), suggesting that 
the opioid peptide/DA receptor colocalization patterns might 
differ between these two nuclei. 
Immunohistochemical studies indicate that ENK and 
DYN peptides are localized primarily in separate popula- 
tions of GABAergic projection neurons throughout the 
striatal complex (Anderson and Reiner, 1990; Reiner and 
Anderson, 1990). There is also evidence indicating that 
ENK and DYN are differentially expressed by the two major 
output pathways of the CPu (Gerfen et al., 1990; Reiner 
and Anderson, 1990). The majority of the neurons project- 
ing to the globus pallidus (striatopallidal pathway) contain 
ENK, whereas the majority of the cells projecting to the 
entopeduncular nucleus andlor the substantia nigra (com- 
monly grouped together as the striatonigral pathway) 
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nucleus. The heterogeneous distribution of a number of 
neuroactive substances within the NAcc has led to the 
breakdown of this nucleus into three major subdivisions, 
which are termed the core, the shell, and the rostral pole 
(Groenewegen and Russchen, 1984; Zaborsky et al., 1985; 
Groenewegen et al., 1991; Heimer et al., 1991; Zahm and 
Brog, 1992) The rostral pole encompasses the most anterior 
portion of the NAcc before the anterior commissure begins 
to move medially away from the external capsule (Zahm 
and Brog, 1992). Coreishell distinctions are made in the 
middle and caudal one-third of the NAcc, with the core 
being centered somewhat asymmetrically around the ante- 
rior commissure and the shell surrounding the core (Zahm 
and Brog, 1992). Tract-tracing studies have found that the 
core receives information from limbic cortical areas (Phillip- 
son and Griffiths, 1985; McDonald, 1991; Brog et  al., 1993) 
but projects to a number of motor output structures, 
including the subthalamic nucleus, the substantia nigra, 
and the entopeduncular nucleus, three regions closely 
associated with the CPu (Groenewegen and Russchen, 
1984; Zahm and Heimer, 1990, 1993; Heimer and Alheid, 
1991; McDonald, 1991; Brog et al., 1993). In contrast, the 
shell is interconnected with more limbic structures, includ- 
ing the VTA, the lateral hypothalamus, and the medial 
prefrontal cortex, three additional regions linked to drug 
reinforcement (Groenewegen and Russchen, 1984; Heimer 
et al., 1991). The rostral pole appears to share characteris- 
tics with both the core and the shell (Zahm and Brog, 1992; 
Zahm and Heimer, 1993). Interestingly, projection neurons 
within these anatomically distinct subregions of the NAcc 
may express different combinations of DA receptors. D1 
and D2 receptor immunoreactivity patterns are heteroge- 
neous within the NAcc (Levey et al., 19931, and binding 
studies suggest that the ratio of D1-like receptors to D2-like 
receptors is greater in the shell than in the core (Bardo and 
Hammer, 1991). Furthermore, D3 receptor mRNA is ex- 
pressed primarily in the rostral pole and the dorsomedial 
shell, with little expression observed in the core (Bouthenet 
et al., 1991; Mansour and Watson, 1995). These findings 
suggest that the opioid peptide/DA receptor colocalization 
patterns may differ not only between the CPu and the NAcc 
but also among the three major subdivisions of the NAcc. 
The goal of this study was to develop a map detailing the 
colocalization of the opioid peptides ENK and DYN with 
D1, D2, and D3 receptors in the NAcc of the rat. Double in 
situ hybridization methods were used to examine the 
coexpression patterns of prodynorphin and proenkephalin 
mRNAs with each other as well as with the three DA 
receptor mRNAs. Colocalization patterns detected in the 
CPu as well as the rostral pole, the core, and the shell of the 
NAcc were compared in order to determine possible differ- 
ences among these anatomically distinct regions. These 
comparisons revealed some similarities between the CPu 
and the NAcc, but unique colocalization patterns were 
observed in the rostral pole and shell subdivisions of the 
NAcc. 
contain DYN. Comparisons of the parallel outputs of the 
NAcc to the ventral pallidum (VP) and the ventral tegmen- 
tal area (VTA) are not as clear, but immunohistochemical 
studies suggest that the NAcc-VTA pathway may be similar 
to the striatonigral pathway, because there are large num- 
bers of DYN-positive fibers within the VTA with far fewer 
ENK-positive fibers (Fallon et al., 1985; Kalivas et al., 
1993). NAcc projections to the VP may be more complex 
than the striatopallidal projections, because the VP has 
been found to share characteristics with both the globus 
pallidus and the entopeduncular nucleus (Haber and Nauta, 
1983; Haber et al., 1985). In addition, the distribution of 
ENK and DYN immunoreactivity within the VP has been 
described as overlapping but distinguishable, implying that 
there could be populations of NAcc-VP cells that contain 
both ENK and DYN as well as populations that contain only 
one of these peptides (Haber and Watson, 1985). Both 
colocalization and tract-tracing studies must be conducted 
to test this hypothesis. 
At present, there are five known DA receptors that 
potentially could be expressed by the striatal ENK and DYN 
cells. These include D1, D2, D3, D4, and D5 receptors 
(Civelli et al., 1991). Pharmacologically, these five DA 
receptors can be resolved only into two major families, the 
D1-like (which includes D1 and D5 receptors) and the 
DZ-like (D2, D3, and D4). Binding studies have found that 
both D1-like and D2-like receptors are abundant in the CPu 
and the NAcc (Boyson et al., 1986; Mansour et al., 1990). In 
situ hybridization studies have further characterized the 
striatal DA receptors, showing that D1 and D2 receptor 
mRNAs are the most abundant and widely distributed in 
the CPu and the NAcc (Meador-Woodruff et al., 1989; 
Civelli et al., 1991; Mansour et al., 1991). D3 receptor 
mRNA is also present in these nuclei, although it is less 
abundant, and its distribution is restricted to the ventrome- 
dial CPu and to parts of the NAcc (Sokoloff et al., 1990, 
1992; Bouthenet et al., 1991 Mansour and Watson, 1995). 
D4 and D5 receptor mRNAs are thought to be present in 
the striatal complex of some species; however, in the rat, 
either these mRNAs are not present or their levels are so 
low that they are not detectable with current in situ 
hybridization techniques (Sunahara et al., 1991; Van To1 et 
al., 1991; Meador-Woodruff et al., 1992). 
DA receptor expression by ENK and DYN projection 
neurons of the CPu is a topic of controversy (see Gerfen, 
1992; Surmeier et al., 19931, but a number of studies 
suggest that there are distinctions. For example, selective 
lesions of the striatopallidal pathway decrease D2 binding 
to a much greater extent than D1 binding in the CPu, 
whereas lesions of the striatonigral pathway decrease D1 
but have no effect on D2 binding (Harrison et al., 1992; 
Pollack et al., 1993). In addition, tract-tracing and/or in 
situ hybridization studies have shown that proenkephalin 
and D2 mRNAs are principally coexpressed in striatopalli- 
dal cells, whereas prodynorphin and D1 mRNAs are princi- 
pally coexpressed in striatonigral cells (Gerfen et al., 1990; 
Le Moine et al., 1990, 1991). It remains to be determined, 
however, whether these opioid peptide/DA receptor relation- 
ships extend into the NAcc. Furthermore, the expression of 
D3 mRNA by DYN and/or ENK cells has not been exam- 
ined in either the CPu or the NAcc. 
D1, D2, and D3 receptor mRNAs and/or proteins have 
distinct distributions within the NAcc, suggesting that 
there may be differences in the expression of these three DA 
receptors by ENK and DYN cells within subregions of this 
MATERIALS AND METHODS 
Tissue preparation 
Tissue was obtained from ten adult male Sprague-Dawley 
rats (250-350 g; Charles River) that were quickly decapi- 
tated. This procedure was conducted in accordance with the 
University of Michigan animal use protocols. The brains 
were removed and frozen in isopentane at  -30°C for 30 
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TABLE 1. Riboprobe Data and Source 
Size 
Riboprobe (bases) Insert1 Reference 
Proenkephalin 693 Bases Exon 3 Yoshikawa et al., 1984 
Prodynorphin 733 Bases Exon 4 Civelli et al., 1985 
D1 receptor 530 Bases TM 111-IV Zhou et al., 1990 
D2 receptor 495 Bases TM VI-VII Bunzow et al., 1988 
D3 receptor 325 Bases Third cytoplasmic loop Sokoloff et al., 1990 
'TM, transmembrane. 
seconds then stored at -80°C until they were cut on a 
Bright cryostat maintained at  -20°C. Ten micrometer 
coronal sections were cut through the rostrocaudal extent 
of the NAcc and CPu, thaw-mounted onto polylysine- 
subbed slides, and stored at  -80°C until used for in situ 
hybridization. 
Probe labeling 
Riboprobes complementary to proenkephalin, prodynor- 
phin, D1 receptor, D2 receptor, and D3 receptor mRNAs 
were used in both single and double in situ hybridization 
studies (for details, see Table 1). Radioactive riboprobes for 
proenkephalin, prodynorphin, D1, and D2 were generated 
by labeling with 250 $3 of 35S-UTP (NEN) using 1 pl of the 
appropriate RNA polymerase in a 25 p1 transcription 
reaction containing 5 p15 x transcription buffer; 2 p10.1 M 
dithiothreitol; 12 p1 sterile water; 1 p1 linearized plasmid (1 
pgipl); 1 pl each of 10 mM stocks of ATP, CTP, and GTP; 
and 1 p1 of RNasin. The transcription reaction was incu- 
bated for 2 hours at 37T,  and then the labeled probe was 
separated from unincorporated nucleotides on a Sephadex- 
G50 column. Radioactive D3 riboprobes were generated in a 
similar manner, except that this probe was labeled with 
both 35S-UTP and 35S-CTP to enhance the signal for this 
relatively rare mRNA. In the double in situ studies, either 
the riboprobes were labeled with 35S as described above, or 
they were labeled with a digoxigenin-UTP (dig-UTP; Boeh- 
ringer Mannheim). This transcription reaction was per- 
formed as recommended by Boehringer Mannheim; in a 20 
p1 final volume, 4 pl 5~ transcription buffer, 2 pl 0.1 M 
dithiothreitol, 9 pl sterile water, 1 p1 linearized plasmid, 2 
p1 rNTP mix (containing 2 pl each of 10 mM ATP, CTP, and 
GTP; 1.3 p110 mM UTP; and 0.7 p110 mM dig-UTP), 1 p1 
RNA polymerase, and 1 p1 RNasin were added. The tran- 
scription reaction was incubated at 37°C for 2 hours and 
was then separated on a G50/50 column. The fraction 
containing the dig-labeled riboprobe was determined by a 
small-scale color reaction (see below) run on 1 p1 aliquots of 
G50/50 fractions blotted onto nytran paper. 
Single in situ hybridization studies 
Single radioactive in situ hybridization studies were 
conducted to develop a distribution map for the proenkepha- 
lin, prodynorphin, D1, and D2 mRNAs. Representative 
adjacent sections through the rostral, middle, and caudal 
extent of the NAcc and the overlaying CPu were hybridized 
with one of the four probes. The order of the probes used for 
hybridization was alternated so that they would be next to 
all of the other three probes at  least twice for each 
rostrocaudal level. In a separate study, the distribution of 
D3 mRNA was analyzed in relation to the opioid peptides. 
Single radioactive in situ hybridization studies were also 
conducted for all five of these probes on sections adjacent to 
those used in the double in situ hybridization experiments. 
This was done to make sure that the distribution of silver 
grains within the striatal nuclei was not altered for a given 
probe by the addition of a second nonradioactive probe (see 
in situ hybridization controls below). 
Prior to hybridization, the sections were removed from 
storage at  -80°C and placed in 4 grams% paraformalde- 
hyde for 1 hour at  room temperature (RT). The slides were 
washed three times in 2x SSC (300 mmoliliter NaC1, 30 
mmol/liter sodium citrate, pH 7.2), treated with proteinase 
K (1 pg/ml) for 10 minutes at  37"C, rinsed in water, and 
acetylated in triethanolamine and acetic anhydride (0.25%) 
for 10 minutes at RT. Following acetylation, the slides were 
rinsed in 2~ SSC and dehydrated through graded alcohols. 
Hybridization and posthybridization steps for the radioac- 
tive in situ hybridization studies were as previously de- 
scribed (Watson et al., 1988). Briefly, the 35S-riboprobes 
were diluted in hybridization buffer to a final concentration 
of 1-2 x lo6  dpm per 35 p1. The hybridization buffer 
contained 50% formamide, 10% dextran sulfate, 3x SSC, 
50 mM phosphate buffer (pH 7.4), l x  Denhardt's solution 
(0.02% polyvinyl pyrrolidone, 0.02% Ficoll, 0.02% bovine 
serum albumin), 0.1 mg/ml yeast tRNA, and 10 mM 
dithiothreitol. The tissue sections were apposed to the 
diluted probe with coverslips and then placed in a hybridiza- 
tion box containing Whatman filter paper moistened with 
50% formamide. The hybridization boxes were then sealed 
and placed in a 55°C oven overnight. The next day, the 
coverslips were removed with 2 x  SSC. The sections were 
washed three times in 2 x  SSC, treated with 200 pgiml 
RNase A at 37°C for 1 hour; rinsed once for 5 minutes each 
in 2~ SSC, IX SSC, and 0 . 5 ~  SSC; washed for 1 hour at 
70°C in 0.1 x SSC; rinsed for 5 minutes in water at RT; and 
then dehydrated through graded alcohols. Dried slides were 
apposed to x-ray film for 1-20 days depending on the 
abundance of the target mRNA. These films were used to 
examine the macroscopic distribution of each mRNA of 
interest. Following apposition to x-ray film, each slide was 
dipped in NTB-2 emulsion, dried, and stored at 4°C. Dipped 
slides were developed according to times determined by test 
slides, counterstained with cresyl violet, and used to exam- 
ine the cellular distribution of each mRNA. 
Double in situ hybridization studies 
The proenkephalin and the prodynorphin riboprobes 
were labeled with dig-UTP as described above. These 
probes were then hybridized simultaneously with D1, D2, 
D3, proenkephalin, orprodynorphin 35S-labeled riboprobes. 
Colocalization maps of the three DA receptor mRNAs with 
the opioid peptide mRNAs and of proenkephalin and pro- 
dynorphin mRNAs with each other were developed using 
adjacent sections through the rostrocaudal extent of the 
NAcc and the overlaying CPu. 
The method for the double in situ hybridization experi- 
ments was similar to the single radioactive in situ method 
but included a few changes. First, during the hybridization 
step, a dig-labeled riboprobe was diluted in 50% hybridiza- 
tion buffer together with a 35S-labeled riboprobe. Second, 
following the last posthybridization SSC wash in the above- 
described protocol, the sections were incubated in a block- 
ing solution (0.1 M phosphate buffer, 0.25% carrageenan, 
0.5% Triton-X 100, pH 7.4) at  RT for 1 hour. The sections 
were then incubated overnight at RT with an alkaline 
phosphatase (AP)-conjugated antidig (sheep antidig-AP, 
Fab fragments; Boehringer Mannheim) diluted 15,000-1: 
30,000 in blocking solution. The next day, the sections were 
washed extensively in 0.1 M phosphate buffer, pH 7.4, 
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followed by two 10 minute washes in Tris-buffered saline, 
pH 7.5, and one 5 minute wash in alkaline substrate buffer 
(ASB; 100 mM Tris base, 150 mM NaC1,50 mM MgC12, pH 
9.5). The slides then underwent a color reaction in ASB 
containing 5% polyvinyl alcohol (w:vol; Sigma; De Block 
and Debrouwer, 1993), 0.45% NBT (vo1:vol; Boehringer 
Mannheim), 0.35% BCIP (vo1:vol; Boehringer Mannheim), 
and 0.024% levamisole (w:vol; Sigma). The slides were 
examined under a microscope to determine when the color 
reaction was completed, with the time ranging from 2 to 10 
hours. Following the color reaction, the slides were washed 
extensively in water, dehydrated quickly in graded alcohols, 
and air dried. Slides were apposed to x-ray film to visualize 
the %-labeled riboprobe and then dipped in Ilford KD-5 
emulsion (Polysciences). The dipped slides were sealed in 
light-tight boxes and stored at 4°C and were then developed 
following periods (determined with test slides) ranging 
from 1 to 8 weeks. The cellular distributions of the radioac- 
tive (silver grains) and nonradioactive (purple precipitate) 
riboprobes were simultaneously visualized with a Zeiss 
Axiophot microscope. 
Data analysis 
The distribution of each mRNA was qualitatively exam- 
ined within the CPu and the NAcc in both the single and the 
double in situ hybridization studies. Those mRNAs with 
similar distributions were further analyzed in the double in 
situ studies by cell counts using an adaptation of the 
fractionator method (Gundersen et al., 1988) to estimate 
the percentage of colocalization. To help determine whether 
there were regional differences within the NAcc, estimates 
of the rostral pole, core, and shell boundaries were made 
based on those described in the rat atlas of Paxinos and 
Watson (1986). The CPu, on the other hand, was subdi- 
vided into dorsolateral, dorsomedial, ventrolateral, and 
ventromedial quadrants. Cell counts were conducted in 
each of these NAcc and CPu compartments. First, within 
each compartment at  four rostrocaudal levels, random 
populations of cells were defined using a 250 x 250 pm grid 
at  ~ 4 0 0  magnification; second, the dig-labeled cells in the 
grid were counted; third, the 35S-labeled cells in the grid 
were counted; and fourth, the number of cells containing 
both the dig-and the 35S signals were counted. These counts 
were then used to estimate the percentage of colocalization 
for the two mRNAs in both the CPu and the NAcc. The D3 
mRNA signal was very low and, in some regions, was not 
easily distinguishable from background, making the data 
from these double in situ experiments incompatible with 
cell counts. The data for this DA receptor, therefore, are 
more qualitative, descriptions being limited to areas of high 
D3 signal that overlap with the opioid peptide mRNAs. 
Specificity controls 
RNase and/or sense-strand controls produced no specific 
signal for the DA receptor mRNAs and the opioid peptide 
mRNAs, as has been shown previously (Mansour et al., 
1990, 1991; Schafer et al., 1990; Day et al., 1993; Mansour 
and Watson, 1995). For the dig-labeled proenkephalin and 
prodynorphin probes, comparisons of the radioactive and 
nonradioactive signals revealed no differences in signal 
distribution. Furthermore, double in situ hybridization 
studies using the same riboprobe labeled with 3 5 s  and dig 
produced double-labeled cells (see Results). For all radioac- 
tive probes, single in situ experiments were conducted on 
sections adjacent to those that were used for double in situ 
studies to confirm that the distribution of the radioactive 
probe was not altered by the presence of the nonradioactive 
probe (i.e., quenching of the radioactive signal by the 
nonradioactive signal). 
RESULTS 
Single in situ hybridization 
Analysis of the autoradiograms from the single radioac- 
tive in situ hybridization experiments (as well as the double 
in situ experiments) revealed similar distribution patterns 
for prodynorphin, proenkephalin, D1 receptor, and D2 
receptor mRNAs within the CPu and the NAcc. All four of 
these mRNAs were relatively abundant in both the CPu 
and the NAcc, as can be seen in Figures 1 and 2. There were, 
however, subtle distinctions in the distribution of these 
mRNAs in both nuclei. For example, proenkephalin, D1 
receptor, and D2 receptor signals were homogeneous within 
the CPu, but prodynorphin signal was present in a patchy 
pattern. This has been described previously and is attrib- 
uted to a higher prodynorphin signal per cell within the 
striosomes of the CPu compared to prodynorphin-positive 
cells within the surrounding matrix (Gerfen et al., 1991). 
Within the NAcc, the distribution patterns for all four of 
these messages were more complex, with areas of high 
signal intensity standing out against areas of low or no 
signal. This was especially clear in more rostral sections, 
where proenkephalin, prodynorphin, and D1 receptor sig- 
nals were high in the ventral NAcc, but D2 receptor signal 
was absent (cf. Figs. 1 and 2). In comparison to the four 
other mRNAs, D3 receptor mRNA signal was weak and had 
a restricted distribution (Fig. 3). The islands of Calleja had 
the greatest D3 receptor signal intensity, but these struc- 
tures did not express either opioid peptide mRNA. In the 
CPu, overlap between the opioid peptides and the D3 
receptor occurred within the ventromedial aspect of this 
nucleus. Within the NAcc, D3 receptor signal was relatively 
robust within the rostral pole and the dorsomedial shell, 
whereas it was much lower in the core. 
Double in situ hybridization analysis 
of the CPu 
Control experiments indicated that the distribution pat- 
terns generated with the nonradioactive in situ hybridiza- 
tion procedure for both the proenkephalin and the prodynor- 
phin mRNAs were indistinguishable from those obtained 
using the standard radioactive procedure. Furthermore, as 
can be seen in Figure 4A, cohybridization of an 35S-labeled 
proenkephalin probe with a dig-labeled proenkephalin probe 
produced double-labeled cells. 
Fig. 1. Darkfield autoradiograms of proenkephalin (Enk; A-D) 
mRNA and prodynorphin (Dyn; A'-D') mRNA in 10 pm coronal 
sections at four rostrocaudal levels through the nucleus accumbens 
(NAcc) and the overlaying caudate putamen (CPu). The proenkephalin 
and prodynorphin in situ hybridization experiments were conducted on 
adjacent or semiadjacent sections (these sections were run in a series of 
four along with the D1 and D2 rihoprobes shown in Fig. 2). Note the 
areas of high signal intensity for both mRNAs within the rostroventral 
NAcc in A and B (see arrow in A for reference). More caudally, this large 
area separated into smaller clusters (C,D); these are especially visible at  
this magnification along the lateral edge of the NAcc extending into the 
fundus striati (see arrow in C for reference). The midline is to  the right 
in all panels. Scale bar = 1.5 mm. 
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The double in situ hybridization studies comparing the 
distributions of proenkephalin and prodynorphin mRNAs 
within the CPu revealed that these two opioid peptide 
mRNAs were primarily in separate cell populations (Fig. 
4B). Only a small number of the proenkephalin-positive 
cells within the CPu ( < 5%) coexpressed prodynorphin 
mRNA and vice versa (Fig. 5). These double-labeled opioid 
peptide cells were scattered throughout the CPu, with no 
apparent regional differences. 
Cohybridization of the opioid peptide riboprobes with DA 
receptor riboprobes suggested that proenkephalin- and 
prodynorphin-positive cells within the CPu differentially 
express D1 and D2 receptor mRNAs. Figure 6A shows that 
D1 receptor and proenkephalin mRNAs were principally in 
separate cells within the CPu (see Fig. 7 for reference). 
However, cell counts revealed a small number of isolated 
proenkephalin-positive cells that expressed D 1 receptor 
mRNA and vice versa (Fig. 5). In contrast, approximately 
95% of the proenkephalin cells within the CPu expressed 
D2 receptor mRNA, and over 90% of the D2-positive cells 
expressed proenkephalin mRNA (Figs. 5, 6B). I t  could not 
be determined in adjacent sections whether the proenkepha- 
lin/D2-negative cells corresponded to the proenkephalin/Dl- 
positive cells, because both populations were rare and were 
scattered through the nucleus. Double in situ hybridization 
analysis of prodynorphin mRNA with D1 or D2 receptor 
mRNA indicated that the opposite DA receptor pattern 
exists for prodynorphin-positive cells within the CPu. All 
observable prodynorphin-positive cells expressed D 1 recep- 
tor mRNA (Fig. 6D), whereas none of these cells coex- 
pressed D2 receptor mRNA (Fig. 6E). The number of 
D1-positive cells detected within the CPu was greater than 
the number of prodynorphin cells, leaving approximately 
10% of the D1 receptor cells prodynorphin-negative (Fig. 5 ) .  
Colocalization of D3 receptor mRNA with proenkephalin 
or prodynorphin mRNAs was difficult because of its low 
abundance. However, groups of D3-positive cells had rela- 
tively high signal in the ventromedial CPu, the dorsomedial 
rostral pole, and the medial shell. Within these regions, D3 
receptor and proenkephalin mRNAs were not colocalized 
(Fig. 6C), but a large number of these D3-positive cells did 
express prodynorphin mRNA (Fig. 6F). These data, com- 
bined with the observation that all prodynorphin-positive 
cells coexpressed D1 receptor mRNA, suggest that there is a 
subpopulation of prodynorphin cells that coexpress D1 and 
D3 receptor mRNAs. 
Double in situ hybridization analysis 
of the NAcc 
The double in situ hybridization experiments revealed 
that the NAcc, in contrast to the CPu, contained a number 
of cells that coexpressed the opioid peptide mRNAs. Clus- 
ters of cells located within the rostral pole and the shell 
subdivisions of the NAcc expressed both proenkephalin and 
prodynorphin mRNAs (Figs. 61, 8A). However, in the core 
of the NAcc and in regions of the rostral pole and shell 
~~ 
Fig. 2. Darkfield autoradiograms of D1 (A-D) and D2 (A'-D') 
receptor mRNAs in sections adjacent or semiadjacent to sections shown 
in Figure 1. Note that areas of high signal intensity for D1 receptor 
mRNA overlap with those seen for proenkephalin and prodynorphin 
(see arrows in A and C for reference). D2 receptor mRNA, on the other 
hand, is not expressed in these regions (see arrows in A' and C'). Scale 
bar = 1.5 mm. 
surrounding these unique cell clusters, the distribution of 
the opioid peptide mRNAs mirrored that of the CPu: In 
these regions, the opioid peptide mRNAs were primarily in 
separate cell populations (Fig. 5) .  Analysis of adjacent 
sections revealed that the proenkephalin cells within the 
opioid peptide cell clusters did not express D2 receptor 
mRNA (Figs. 6H, 8B). Interestingly, the proenkephalin 
cells located in these cell clusters did express D1 receptor 
mRNA (Figs. 6G, 9A). Furthermore, the prodynorphin cells 
present within these cell clusters, like those outside the 
clusters, expressed D1 receptor mRNA but not D2 receptor 
mRNA (data not shown). However, the proenkephalin cells 
outside the cell clusters displayed the standard CPu-like 
colocalization pattern (see Fig. 5 ) :  These proenkephalin 
cells primarily coexpressed D2 receptor mRNA but not D1 
receptor mRNA (Figs. 6H, 9B). Together, these data sug- 
gest that there are clusters of cells scattered through the 
NAcc that coexpress both opioid peptide mRNAs as well as 
D1 receptor mRNA but are devoid of D2 receptor mRNA 
(proenkephalin/prodynorphin/Dl cell clusters). In addi- 
tion, the core of the NAcc and regions surrounding the 
proenkephalin/prodynorphin/Dl cell clusters have opioid 
peptide/DA receptor colocalization patterns similar to those 
ofthe CPu (Fig. 5). 
The distribution of the proenkephalin/prodynorphin/Dl 
cell clusters is illustrated in Figure 10. The ventral portion 
of the rostral pole contained a large cluster of proenkephalini 
prodynorphin/Dl cells (Fig. 10B). Rostromedial and caudo- 
lateral portions of the olfactory tubercle appeared to have 
extensions of this cluster. In more caudal sections, the 
ventral proenkephalin/prodynorphin/Dl cluster appeared 
to separate into smaller clusters that were dispersed through 
the shell subregion of the NAcc (Fig. 10A,C-E). One of 
these smaller clusters was present along the lateral edge of 
the NAcc and extended caudally into the fundus striati (Fig. 
10E). This lateral cluster was still apparent in the most 
caudal sections examined in this study (Bregma 0.48 mm in 
Paxinos and Watson, 1986). Other proenkephaliniprodynor- 
phin/Dl cell clusters existed within the medial and ventral 
portions of the NAcc along the core/shell border or in 
proximity to the islands of Calleja (Fig. 10C-E; compare 
also to Fig. 11). 
Examination of the proenkephalin/prodynorphin/Dl cell 
cluster regions in single in situ hybridization studies sup- 
ported the double in situ hybridization data. Figures 1 and 
2 show that the signal intensities for the opioid peptide 
mRNAs and the D1 receptor mRNA were higher in regions 
that overlap with the proenkephalin/prodynorphin/Dl cell 
clusters (compare to Fig. 10). This was especially visible in 
the ventral zone of the rostral pole and along the lateral 
edge of the NAcc extending back into the fundus striati (see 
arrows in Figs. 1, 2). These regions were devoid of D2 
receptor mRNA signal (Fig. 2). An inspection of these 
regions at  the cellular level (in dipped sections counter- 
stained with cresyl violet) indicated that the proenkephalini 
prodynorphin/Dl cell clusters corresponded to areas of 
densely packed Nissl-stained cells compared to surrounding 
regions (Fig. 11). 
The autoradiograms for D3 receptor mRNA (Fig. 3) 
suggested that, at  least within the ventral region of the 
rostral pole, D3 receptor mRNA may be present in the 
proenkephalin/prodynorphin/Dl cell clusters. A further 
analysis of these regions in emulsion-dipped sections from 
either the single or the double in situ hybridization experi- 
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Fig. 4. Photomicrographs of double in situ hybridization experi- 
ments using dual film exposures to view both the nonradioactive 
(brightfield; dark cells) and the radioactive (darkfield; silver grains) 
signals. A: Cells within the CPu of a control section that was hybridized 
with both a digoxigenin (dig)-labeled proenkephalin probe and 'a 
35S-labeled proenkephalin probe. All positive cells within the CPu and 
the NAcc showed both the nonradioactive and the radioactive signal. 
The arrow points to an example of this double labeling. B: Illustration 
showing that proenkephalin (dark cells; arrow) and prodynorphin 
(silver grains; arrowhead) mRNAs are primarily in separate cells within 
the CPu. Scale bar = 50 pm. 
ments was not conclusive, however, due to the low D3 
receptor signal intensity in this region. 
DISCUSSION 
The present study examined the colocalization patterns 
of opioid peptide mRNAs and DA receptor mRNAs within 
the dorsal and ventral striatum of the rat. Comparisons 
among the rostra1 pole, core, and shell subterritories of the 
NAcc as well as between the NAcc and the CPu were 
conducted to determine whether there are differences across 
these anatomically distinct regions. In the CPu, three 
distinguishable opioid peptide cell populations were de- 
tected based on colocalization of proenkephalin and pro- 
dynorphin mRNAs with each other as well as with D1, D2, 
and D3 receptor mRNAs. The two most abundant and 
widespread configurations within the CPu were proenkepha- 
lin/D2 and prodynorphin/Dl cells. Additionally, within the 
ventromedial CPu, a subpopulation of prodynorphin cells 
expresses D3 receptor mRNA, suggesting that a prodynor- 
phinlDliD3 configuration exists in this subregion of the 
CPu. Within the NAcc, on the other hand, four distinguish- 
able opioid peptideiDA receptor configurations were de- 
tected. The two most prevalent populations seen in the 
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Fig. 5. Bar graph illustrating the percentage of colocalization 
between proenkephalin (Enk), prodynorphin (Dyn), D1 receptor, and 
D2 receptor mRNAs. Solid bars represent the percentage of dig-labeled 
cells (mRNA in boldface) that were also labeled by 35S (mRNAin italics). 
Conversely, hatched bars represent the percentage of 35S-labeled cells 
in the same samples that were also labeled by dig. The numbers above 
each bar represent the actual number of dig-labeled (solid bars) or 
35s-labeled (hatched bars) cells counted. The CPu and the NAcc were 
divided into subregions at  four rostrocaudal levels, and representative 
cells were counted in each of these regions on both sides of the brain 
4 n = 3  n = 3  
(see Materials and Methods). No regional or rostrocaudal differences 
were noted in the three or four animals that were used for each 
combination of counts. Therefore, the numbers generated from cell 
counts within the CPu and the NAcc were combined to produce the 
estimates of colocalization for a particular animal. It should be noted 
that the cell counts within the NAcc avoided the proenkephalini 
prodynorphiniD1 cell clusters (see text). The data for colocalization 
between D2 receptor and prodynorphin mRNA are not shown, because 
these two mRNAs did not colocalize at  any time. 
Fig. 6. A-I: Photomicrographs of double in situ hybridization 
experiments illustrating opioid peptideiDA receptor or opioid peptidei 
opioid peptide mRNA expression patterns in the CPu and the NAcc. 
The photomicrographs were generated using dual film exposures on 
color slide film to view simultaneously the nonradioactive (brightfield) 
and the radioactive (darkfield) signals. To add contrast, the darkfield 
exposure was taken with a green filter. The color slides were then 
digitally scanned onto a Kodak photo CD using a Kodak PCD Film 
Scanner 2000. The scanned images were imported into Adobe Photo- 
shop (version 2.5.11, where they were grouped together; the borders 
were cropped, and the panels were labeled. Images were adjusted for 
color balance to produce a uniform tone across panels. In all panels, the 
dig-labeled probe (purple cells) is listed first, and the radioactive probe 
(green grains) is listed second. The pink arrows indicate double-labeled 
cells, the white arrows indicate single dig-labeled cells, and the black 
arrows indicate single 35S-labeled cells. A, B, D, and E are from the CPu, 
whereas C, F, G, H, and I are from the NAcc. See Figure 7 for a diagram 
illustrating the approximate level, region, and orientation of each panel. 
A illustrates that the majority of proenkephalin-positive cells within 
the CPu do not express D1 receptor mRNA. In contrast, as shown in B, 
the majority of proenkephalin-positive cells within the CPu do express 
D2 receptor mRNA. Small numbers of D2-positive cells do not express 
proenkephalin mRNA (black arrow in B). All observable prodynorphin- 
positive cells within the CPu, as opposed to proenkephalin, expressed 
D1 receptor mRNA (D), but none of these cells expressed D2 receptor 
mRNA (El. D3 receptor mRNA expression by proenkephalin (C) and 
prodynorphin (F) cells was examined in the rostral pole, medial shell, 
and ventromedial CPu. C and F are from the medial shell (see Fig. 7) 
but represent the other two regions as well. Analyses of the observable 
D3-positive cells suggest that proenkephalin and D3 mRNAs are not 
colocalized (0, whereas a large number of the D3-positive cells do 
express prodynorphin mRNA (F). The CPu-like proenkephaliniD2 and 
prodynorphiniD1 expression patterns are also detected within the 
NAcc. However, embedded in this background, clusters of cells within 
the rostral pole and the shell exist that coexpress proenkephalin, 
prodynorphin, and D1 receptor mRNAs, but they are devoid of D2 
receptor mRNA. The lower left corners in G-I illustrate this expression 
pattern in a cluster located along the lateral edge of the NAcc (see Fig. 
7). Notice that the cells outside this cluster (top portion in G-I) express 
a CPu-like pattern. Scale bar = 50 km. 
Figure 6 
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Fig. 7. Diagram illustrating the approximate level, striatal region, 
and orientation (A-I are positioned at the top) corresponding to the 
photomicrographs in Figure 6A-I. 
rostral pole, core, and shell subdivisions of the NAcc were 
proenkephaliniD2 and prodynorphiniD1 cells. Addition- 
ally, tightly packed clusters of proenkephaliniprodynor- 
phin/Dl cells were detected in the ventral rostral pole and 
dispersed through the shell. Similar proenkephalini 
prodynorphiniD1 cell clusters were not detected within the 
CPu, suggesting that these structures are unique to the 
NAcc. Finally, as with the ventromedial CPu, prodynorphini 
DlID3 cells were found in the rostral pole and medial shell 
of the NAcc. 
Opioid peptide/DA receptor colocalization 
Comparisons between the CPu and the NAcc indicate 
that these two nuclei share some opioid peptideiDA recep- 
tor colocalization combinations. All of the prodynorphin 
cells in the CPu were observed to express D1 receptor 
mRNA, but none expressed D2 receptor mRNA. Con- 
versely, the majority of the proenkephalin cells within the 
CPu expressed D2 receptor mRNA, whereas only a few 
isolated proenkephalin cells expressed D1 receptor mRNA. 
Proenkephalin and prodynorphin cells in the core of the 
NAcc and in regions of the rostral pole and shell surround- 
ing the proenkephaliniprodynorphiniD1 cell clusters also 
expressed these colocalization patterns. 
D3 receptor mRNA was present in the NAcc and the CPu, 
but its signal intensity was much lower, and it had a 
restricted distribution compared to D1 receptor and D2 
receptor mRNA. The highest level of D3 receptor mRNA 
expression was observed within the islands of Calleja, 
structures that do not express either opioid peptide mRNA. 
The rostral pole and the shell of the NAcc as well as the 
most ventromedial portion of the CPu also expressed D3 
receptor signal. The low signal intensity for some of these 
regions made it difficult to determine whether there was 
colocalization with the opioid peptide mRNAs. However, 
clear groups of D3-positive cells were visible within the 
medial rostral poie, medial shell, and ventromedial CPu. 
Many of these D3-positive cells expressed prodynorphin 
mRNA, but none expressed proenkephalin mRNA. To- 
gether with the prodynorphiniD1 data, the D3 receptor 
data suggest that a subpopulation of prodynorphin cells 
within the medial NAcc and the ventromedial CPu ex- 
presses D1 receptor and D3 receptor mRNAs. Anatomical 
analysis of the ventromedial CPu has led Heimer and his 
colleagues (1982) to associate this region more closely with 
the ventral striatum (i.e., the NAcc and the olfactory 
tubercle) rather than with the rest of the CPu. Further- 
more, a comparison of the afferents and efferents for the 
regions that express prodynorphiniDliD3 cells to regions 
that do not suggests that the prodynorphiniDliD3 cells are 
associated with limbic regions of the ventral striatum 
(Groenewegen et al., 1991; Heimer et al., 1991; Zahm and 
Brog, 1992). 
Previous studies have reported the differential expres- 
sion of D1 receptor and D2 receptor mRNAs by the opioid 
peptide cells of the CPu (Gerfen et al., 1990; Le Moine et al., 
1990, 19911, and this has led to the conclusion that these 
two receptors are generally in separate cell populations 
within the striatum. This hypothesis, however, does not 
correlate with the electrophysiological and antisense RNA 
amplification data of Surmeier and his colleagues (Sur- 
meier et al., 1992, 1993). These studies suggest that the 
majority of the striatal projection neurons contain both D1 
and D2 receptors. Taken together, analyses of D1 and D2 
receptor colocalization have produced estimates ranging 
from approximately 15% to virtually complete colocaliza- 
tion (Gerfen et al., 1990; Le Moine et al., 1990, 1991; 
Meador-Woodruff et al., 1991; Ariano et al., 1992; Gerfen, 
1992; Surmeier et al., 1992, 1993; Lester et al., 1993). The 
different percentages appear to depend on the technique 
used to determine colocalization as well as the definition of 
the cell populations under investigation. Although the 
present study did not directly address this issue, the data 
are consistent with the possible existence of a small percent- 
age of cells expressing D1 receptor and D2 receptor mRNAs. 
For example, although all prodynorphin cells observed in 
our study expressed D1 receptor mRNA, not all D1-positive 
cells expressed prodynorphin mRNA. Furthermore, not all 
D2-positive cells expressed proenkephalin mRNA. Any pro- 
portion of these cells theoretically could express D1 recep- 
tor and D2 receptor mRNAs. The present study also 
provides evidence for the coexpression of D1 receptor and 
D3 receptor mRNAs by a subset of prodynorphin cells, 
indicating that D1- and D2-like receptor families are colocal- 
ized in some cells within the ventral striatum. 
It is possible that low levels of mRNA were not detected 
in the present study. This would suggest that we are 
underestimating the amount of colocalization between each 
DA receptor and each opioid peptide mRNA. Especially 
relevant to the above-mentioned controversy is the distribu- 
tion of the D1, D2, and D3 receptor mRNAs. However, 
comparisons of binding and/or immunohistochemical distri- 
butions for these substances and our mRNA distributions 
DA RECEPTOR EXPRESSION BY NAcc OPIOID PEPTIDE CELLS 69 
Fig. 8. A double in situ hybridization experiment in adjacent 
sections comparing the colocalization patterns of prodynorphin (silver 
grains) and proenkephalin (dark cells) mRNAs (A) to those of D2 
receptor (silver grains) and proenkephalin (dark cells) mRNAs (B) 
within the rostral pole of the NAcc. A and B illustrate the border 
between a large ventral cluster of proenkephalin cells (bottom) that 
have a unique expression pattern compared to surrounding regions, 
which express the typical CPu-like pattern (Fig. 10B shows a low- 
magnification photomicrograph of this cluster). proenkephalin cells 
suggest that we are probably seeing most of the striatal cells 
that express these DA receptors. To date, no immunohisto- 
chemical data are available for the D3 receptor, but D3 
binding sites defined by 7-OH-DPAT and 7-trans-OH- 
PIPAT correspond with the distribution of D3 mRNA we 
report here (Levesque et al., 1992; Murray et al., 1992; 
McGonigle et  al., 1993). Immunohistochemical and binding 
analyses of D1 and D2 receptors within the NAcc and CPu 
also show a high level of correspondence with the distribu- 
tion of the D1 and D2 receptor mRNAs observed in the 
present study (Mansour et al., 1990, 1991; Levey et al., 
1993). 
Proenkephalin/prodynorphin/Dl cell clusters 
The anterior NAcc contained a large cluster of proen- 
kephalin/prodynorphin/Dl cells within the ventral rostral 
pole. This large cluster separated into smaller cell aggre- 
gates in more caudal sections. In the more caudal sections, 
proenkephalin/prodynorphin/D 1 cells aggregated along the 
lateral edge of the NAcc, within the coreishell border 
region, and along the medial and ventral border of the NAcc 
within the ventral cluster express prodynorphin mRNA (A, black 
arrows) but do not express D2 receptor mRNA (B, white arrows). 
Outside this cluster, proenkephalin (A, white arrow) and prodynorphin 
(A, arrowhead) mRNAs are in separate cells, whereas proenkephalin 
and D2 receptor mRNAs are colocalized (B, black arrow). In the 
transition area between the cluster and the noncluster region, there are 
a number of D2-positive cells that do not express proenkephalin mRNA 
(B, arrowhead). Scale bar = 50 pm. 
in proximity to the islands of Calleja. Interestingly, unlike 
the colocalization of proenkephalin and D2 receptor mRNAs 
seen in surrounding regions, D2 receptor mRNA was not 
expressed by proenkephalin cells within these clusters. The 
results from the single in situ hybridization experiments 
indicated that these proenkephaliniprodynorphiniD 1 cells 
can be observed within Nissl-stained material as clusters of 
more densely packed cells compared to surrounding re- 
gions. The present data suggest, therefore, that the proen- 
kephaliniprodynorphiniD1 cell clusters correspond, at  least 
in part, to clusters of cells previously described by Herken- 
ham and his colleagues (1984). In their experiments, Nissl- 
stained sections through the NAcc were found to contain 
clusters of densely packed cells located in the ventral rostral 
pole, along the lateral edge, within the medial and ventral 
shell, and along the coreishell border region. However, 
these investigators (Herkenham et al., 1984) reported 
several clusters in more central and dorsal areas of the 
NAcc, where we did not see corresponding proenkephalini 
prodynorphin/Dl clusters. Therefore, it appears that the 
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Fig. 9. A double in situ hybridization experiment comparing the 
colocalization pattern of proenkephalin mRNA (dark cells) with D1 
receptor (silver grains; A) or D2 receptor (silver grains; B) mRNAs. A 
and B show a cluster located in the medial shell of the NAcc (left is 
medial; Fig. 10D shows a low-magnification photomicrograph of this 
cluster). On the left in both A and B, there is a cluster of proenkephalin 
cells that express D1 receptor mRNA (A, black arrows) but do not 
express D2 receptor mRNA (B, white arrows). Outside the cluster, 
proenkephalin (A, white arrows) and D1 receptor (A, black arrowhead) 
mRNAs are in separate cells, whereas proenkephalin and D2 receptor 
mRNAs are colocalized (B, black arrow). 
Fig. 10. A-E: Distribution of proenkephaliniprodynorphiniD1 cell 
clusters within the NAcc. A illustrates where these clusters were 
observed in six animals at four rostrocaudal levels. Low-magnification 
photomicrographs of representative sections at the levels in A are 
shown in B-E, which illustrate the distribution of a dig-labeled 
proenkephalin probe (dark cells) in double in situ hybridization experi- 
ments. Adjacent sections were used to analyze the colocalization of the 
dig-labeled proenkephalin probe with 35S-labeled prodynorphin, D1 
receptor, or D2 receptor probes. Smaller proenkephaliniprodynor- 
phiniDl cell clusters are marked with arrows, whereas larger clusters 
are outlined with dashed lines. B: The ventral rostra1 pole contained a 
large cluster of cells that coexpressed proenkephalin, prodynorphin, 
and D1 receptor mRNAs, but these cells were devoid of D2 receptor 
mRNA. High-magnification photomicrographs of cells at  the border of 
this ventral cluster ( 8 )  are shown in Figure 8. C-E: In more caudal 
sections, this large ventral proenkephaliniprodynorphiniD1 cell clus- 
ter separated into smaller clusters that were dispersed through the 
medial, ventral, and lateral shell subregion of the NAcc [Fig. 9 displays 
high-magnification photomicrographs of the medial cluster (9) shown 
in Cl. ac, Anterior commissure; Tu, olfactory tubercle; ICj, islands of 




Fig. 11. Darkfield photomicrographs of semiadjacent sections pro- 
cessed for single in situ hybridization with a "S-labeled proenkephalin 
probe (A) or a 35S-labeled D2 receptor probe (B). The sections were 
dipped in emulsion to visualize the silver grains and then stained with 
cresyl violet. The NAcc contains clusters of cells that express proen- 
kephalin mRNA but not D2 receptor mRNA. Adjacent sections revealed 
that cells within these clusters did express D1 receptor and prodynor- 
phin mRNAs (data not shown). Two of these proenkephalin cell clusters 
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that are in close proximity to the ICj are shown in A (white arrow and 
inset). The corresponding regions in B do not express D2 receptor 
mRNA. C,D: Higher magnification photomicrographs of the insets in A 
and B, respectively. Note that cells within the cluster contain proen- 
kephalin signal (C), but they are devoid of D2 receptor signal (D). Also 
note that the cells within this cluster (bottom) are more densely packed 
than the cells outside the cluster (C,D, top). Scale bars = 150 pm in A,B, 
30 pm in C,D. 
proenkephaliniprodynorphiniD1 clusters may be a subset 
of the Nissl-cell clusters. 
Comparisons between the CPu and the NAcc suggest 
that, like the compact Nissl-stained clusters described by 
Herkenham et al. (19841, the proenkephaliniprodynor- 
phin/Dl clusters are not present in the CPu. A small 
number of the proenkephalin-positive cells in the CPu were 
observed to coexpress either D1 receptor or prodynorphin 
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mRNAs. However, these isolated cells were rare and were 
scattered through the nucleus, making it difficult to deter- 
mine whether all three mRNAs were expressed in the same 
cells. These findings suggest that it is feasible that there are 
a few proenkephalin/prodynorphin/Dl cells within the 
CPu, but, if they exist, they are rare and they do not 
aggregate together as is seen in the NAcc. 
Studies examining the immunoreactivity or receptor 
binding patterns for a number of neuroactive substances in 
the NAcc have reported complex relationships with the 
Nissl-cell clusters (Herkenham et al., 1984; Zahm and 
Heimer, 1988; Voorn et al., 1989; Zahm and Brog, 1992; 
Jongen-Relo et al., 1993). Herkenham et al. (1984) found 
that the densely packed cells in Nissl-stained material 
corresponded extensively with 3H-naloxone binding as well 
as with areas of weak acetylcholinesterase (AChE) staining. 
Voorn et al. (1989) reported that cell clusters in the shell 
and its border coincide with zones of weak enkephalin, 
substance P, and DA immunoreactivity. On the other hand, 
analysis of substance P immunoreactivity (Zahm and Hei- 
mer, 1988; Zahm and Brog, 1992) through the rostrocaudal 
extent of the NAcc revealed that there is a large cluster of 
tightly packed cells within the basal parts of the rostral pole 
that exhibits dense substance P immunoreactivity. Append- 
ages of this immunohistochemically distinct district extend 
into rostral parts of the olfactory tubercle and laterally into 
an adjoining densely substance P-immunoreactive lamina, 
called the lateral stripe (Zahm and Heimer, 1988; Zahm and 
Brog, 1992). Comparisons of the basal cluster and the 
lateral stripe with 3H-naloxone binding and areas of weak 
AChE staining show significant overlap (Zahm and Brog, 
19921, suggesting that these substance P-rich areas coin- 
cide with the Nissl-cell clusters. However, as noted above, 
smaller clusters that exhibit weak immunoreactivity for 
substance P, enkephalin, and DA within the medial shell 
and the coreishell border region also correspond to opiate 
receptor-rich and AChE-poor clusters, suggesting that there 
may be neurochemically distinct subsets of the Nissl-cell 
clusters (Zahm and Heimer, 1988; Voorn et al., 1989; Zahm 
and Brog, 1992). Overlaying the distribution of the proen- 
kephaliniprodynorphiniD1 cell clusters with the immuno- 
histochemically distinct clusters described above reveals an 
additional level to the heterogeneity of the Nissl-cell clus- 
ters. First, like the substance P-rich zones, the proenkepha- 
liniprodynorphinlD1 clusters are seen in the basal portion 
of the rostral pole as well as the lateral stripe. However, 
proenkephalinlprodynorphiniD1 clusters were also found 
in close association with the islands of Calleja in the ventral 
and medial NAcc as well as along the coreishell border, 
suggesting that these proenkephalin/prodynorphin/Dl cells 
may correspond, at  least in part, to the substance P-poor 
clusters described by Voorn et al. (1989). 
The absence of D2 receptor mRNA in the proenkephalini 
prodynorphiniD1 clusters was quite striking. Immunohis- 
tochemical (Levey et  al., 1993) and binding (Berendse and 
Richfield, 1993) analyses of D1 and D2 receptors within the 
NAcc by other investigators suggest that this differential 
distribution may also occur in other species. In a recent 
study by Levey et al. (19931, the immunoreactivity patterns 
for D1 and D2 receptor proteins were expressed in distinct 
heterogeneous patterns within the NAcc of the rat, mon- 
key, and human brain. The patterns described for the D1 
and D2 receptor proteins in the NAcc by these authors 
correspond to some extent with distributions we see for the 
mRNAs. In another study examining the relationship of D1 
and D2 receptor binding in the NAcc of human brain, 
Berendse and Richfield (1993) found that areas of high D1 
binding and low D2 binding in caudal sections overlapped 
with areas of high cell density. Although it is not clear 
whether these regions are analogous to the cell clusters 
observed in rat, it will be interesting for future studies to 
examine opioid/DA colocalization patterns in primate tis- 
sue. 
NAcc circuitry 
Comparisons of the efferents of the rostral pole, shell, 
and core regions reveal that the core projects robustly to 
conventional basal ganglia circuitry through the dorsolat- 
era1 VP as well as the entopeduncular nucleus (Heimer et 
al., 1991). Efferents of the shell and portions of the rostral 
pole, on the other hand, bypass these regions and terminate 
in the ventromedial VP and nontraditional areas, including 
parts of the bed nucleus of the stria terminalis, the lateral 
preoptic region, the sublenticular substantia innominata, 
and the entire length of the lateral hypothalamus (Zahm 
and Heimer, 1990; Heimer et al., 1991; Zahm and Brog, 
1992). These projection patterns have led Alheid and 
Heimer (Alheid and Heimer, 1988; Heimer and Alheid, 
1991) to postulate that the shell of the NAcc consists of 
both traditional striatal-like characteristics as well as at- 
tributes of the extended amygdala. Analysis of NAcc affer- 
ents indicates a general topographic order that generally 
obeys coreishell boundaries, but the shell has an additional 
suborganization, where some of the shell afferents appear 
to avoid and others to innervate preferentially the Nissl-cell 
clusters (Groenewegen et al., 1991; Zahm and Brog, 1992). 
A number of thalamic inputs, including anterior and poste- 
rior paraventricular, paratenial, and central medial nuclei, 
were found to avoid the Nissl clusters (Herkenham et al., 
1984). Analysis of hippocampal and medial frontal cortex 
input to the clusters suggests that projections from the 
hippocampus and the ventral subiculum avoid, whereas the 
ventral and deep dorsal prelimbic areas of the medial 
prefrontal cortex preferentially innervate, the clusters 
(Herkenham et al., 1984; Groenewegen et al., 1987; Ber- 
endse et al., 1992a). Input from the VTA, on the other hand, 
has a less pronounced difference (Zahm and Heimer, 1993), 
but it has been noted that Nissl clusters appear to receive 
less dense innervation compared to surrounding regions 
(Herkenham et al., 1984). The efferent targets of the 
Nissl-cell clusters have not been extensively studied, but 
there is some evidence that these areas do not project 
directly to the VTA or the substantia nigra (Berendse et al., 
1992b). Other studies involving injections of a retrograde 
tracer into the VP suggest that the clusters may project to 
this pallidal region, but it is possible that this study was 
picking up fibers passing through the VP on their way to 
the lateral hypothalamus (Zahm and Brog, 1992). The 
location of the Nissl-cell clusters in apparent transition 
zones within the NAcc (such as the rostrobasal area and 
along the medial and lateral edges) plus the finding that the 
lateral stripe appears to extend caudally into the amygdala 
with no clear boundaries between this cluster and the 
intercalated cell islands of the amygdala (Herkenham et al., 
1984) suggest that these structures may be relevant to 
communication with the extended amygdala (Herkenham 
et al., 1984; Heimer and Alheid, 1991; Zahm and Heimer, 
1993). Future studies will, therefore, examine the efferent 
connections of these cell clusters more fully to help deter- 
mine how these cells are interrelated to the classical basal 
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types are differentially expressed in the rostra1 pole, the 
core, and the shell, suggesting that the opioid peptide 
efferents within the these three subregions of the NAcc 
have distinct DA receptor environments. Future tract- 
tracing studies focusing on the projection targets of these 
four opioid peptideiDA receptor cell types may, therefore, 
help integrate NAcc circuitry data with results from func- 
tional studies that have examined opiate-DA interactions 
within the NAcc. 
ganglia circuitry as well as to the extended amygdala 
circuitry. 
DA-opioid interactions in the NAcc 
Behaviorally, DA-opioid interactions within the NAcc 
have been implicated in the reinforcing properties of two 
major classes of abused drugs, the psychomotor stimulants 
and the opiates (for a review, see Cooper, 1991). Analyses of 
D1- and D2-specific drugs have shown that the two DA 
receptor families produce distinct effects in reinforcement 
paradigms. Systemic and intraaccumbens injections of D1 
and D2 agonists produce place preferences (White et al., 
1991), but only D1 antagonists produce place aversions, 
whereas D2 antagonists are motivationally neutral (Ship- 
penberg and Herz, 1987; Shippenberget al., 1991). Further- 
more, the positive reinforcing effects of mu-opiate drugs 
and the negative reinforcing effects of kappa-opiate drugs 
are preferentially disrupted by D1 antagonists (Shippen- 
berg and Herz, 1988). These data suggest that both D1- and 
D2-like receptors can access the reward circuitry of the 
NAcc. There is not a complete overlap, however, because 
only D1-like receptors can interfere with the positive 
reinforcing circuits accessed by mu-opiate drugs, and only 
D1 receptors access circuitry involved in place aversions. 
Although it must be determined, the localization of mu 
receptor binding (defined by 3H-naloxone) to the Nissl-cell 
clusters together with our finding that D1 receptors, but 
not D2 receptors, are present in the proenkephalini 
prodynorphiniD1 subset of these cell clusters suggests that 
these specializations may be a critical site for D1 and 
mu-opiate receptor interactions within the NAcc. 
Both the psychomotor stimulants and the opiates pro- 
duce reinforcing effects as well as locomotor effects when 
injected systemically or directly within the NAcc (Cooper, 
1991). Circuitry data suggest that these functions may be 
processed primarily by different subdivisions of the NAcc. 
For example, the core projects directly and indirectly to a 
number of subcortical structures that have been linked to 
motor behaviors, including the substantia nigra, the entope- 
duncular nucleus, and the subthalamic nucleus (Groenewe- 
gen and Russchen, 1984; Groenewegen et al., 1991; Heimer 
et al., 1991). The shell, on the other hand, is interconnected 
with three other brain sites that have been linked to drug 
reinforcement; the VTA, the lateral hypothalamus, and the 
medial prefrontal cortex (Groenewegen and Russchen, 1984; 
Groenewegen et al., 1991; Heimer et al., 1991; Wise and 
Hoffman, 1992). In the present study, we observed differ- 
ences in the DA receptor environments between the core 
and the shell. Two unique opioid peptide1DA receptor 
expression patterns are seen in the shell; proenkephalini 
prodynorphiniD1 cells and prodynorphiniDliD3 cells. The 
core, on the other hand, expresses opioid peptideiDA 
receptor combinations that are identical to those of the 
CPu, which has also been associated with motor behaviors. 
Although they must be examined carefully in future stud- 
ies, the above-described data suggest that the DA receptor 
environment observed within the shell may contribute to 
the processing of drug reinforcement properties within the 
NAcc. 
CONCLUSIONS 
The present study describes prodynorphiniD1, proen- 
kephalinlD2, prodynorphiniDliD3, and proenkephalini 
prodynorphiniD1 cells within the NAcc. These four cell 
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